glp-1 forms PDB-101: Molecule of the Month: Receptor Agonists Tested Reactivity Are Pills the Next Big

Cosmos Study May 28, 2026 Dual-Team Study Team A:Kersten Bartelt, RNBenjamin GuilliatJoe Deckert, PhD Team B:Louis Kazaglis, MDJacob GasserJoel Simon Key Findings Three months after stopping a GLP-1, 40% of patients had further improved their HbA1c compared to when they discontinued the GLP-1, 48% kept some of their improvement, and just 12% had a worse HbA1c compared to their pre-GLP-1 level

An endoplasmic reticulum (ER) membrane complex composed of SPFH1 and SPFH2 mediates the ER-associated degradation of inositol 1,4,5-trisphosphate receptors

Sensorimotor white matter projections and disease severity in primary restless legs syndrome/WillisEkbom disease: a multimodal DTI analysis

Current research does not conclusively show that medically supervised GHK-Cu therapy causes cancer

So, What is Platelet-Rich Plasma